Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Booster doses of Covaxin improve protection against the Omicron variant.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

Matriptase imbalance contributes to cancer development and spread.

TPA is about 50 times more effective at promoting tumors than MZ.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

A new one-step test can quickly identify skin cancer during surgery.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Ozenoxacin reduces sebum production, helping manage acne.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

PT-20 did not significantly improve gray hair repigmentation.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.